Market Access | eMAX Health

Health Systems at the Crossroads of Access: Why Provider Insights Matter

Health Systems at the Crossroads of Access: Why Provider Insights Are as Critical as Payer Input Market access strategy often centers on payers. Rebates, contracting, and formulary placement dominate the conversation. But in today’s environment, that view is...

MAVA in Action: Launch Strategy Shifted in Just 5 Days

Launch plans rarely survive first contact with payers. One immunology manufacturer learned this firsthand. Their internal strategy had a clear value story, aligned teams, and a rebate framework they believed would secure access. Then they tested it with MAVA®. Launch...

Inside the Decision Room: How to Pressure-Test Your Value Story for Formulary Success

Inside the Decision Room: What Really Drives Formulary Placement Last week, we explored how payers are scrutinizing endpoints and comparators more closely than ever, and why validating your value story against payer expectations has become essential. But validation is...

How Payers Are Scrutinizing Endpoints and What Evidence Resonates Most in 2025

How Payers Are Scrutinizing Endpoints and What Evidence Resonates Most in 2025 For decades, pharmaceutical market access conversations revolved around price. Could a manufacturer justify a premium? Would contracting or rebates secure preferred placement? In 2025,...

The New Normal of Iterative Market Access: Why Static Annual Research is Dead

For years, pharmaceutical manufacturers relied on static research cycles. Advisory boards, annual payer interviews, and one-time market surveys shaped pricing, access, and contracting strategies. The strategy was to gather input once, align internally, and move...

Health Systems at the Crossroads of Access: Why Provider Insights Matter

MAVA in Action: Launch Strategy Shifted in Just 5 Days

Inside the Decision Room: How to Pressure-Test Your Value Story for Formulary Success

How Payers Are Scrutinizing Endpoints and What Evidence Resonates Most in 2025

The New Normal of Iterative Market Access: Why Static Annual Research is Dead

Search by Category:

Recent Posts:

Search by Keyword:

Health Systems at the Crossroads of Access: Why Provider Insights Matter

MAVA in Action: Launch Strategy Shifted in Just 5 Days

Inside the Decision Room: How to Pressure-Test Your Value Story for Formulary Success

How Payers Are Scrutinizing Endpoints and What Evidence Resonates Most in 2025

The New Normal of Iterative Market Access: Why Static Annual Research is Dead

Search by Category:

Recent Posts:

Search by Keyword:

Cookie Consent

Your Privacy Choices

Strictly Necessary (Always Active)

Analytics & Performance

Marketing & Advertising